MenoPro is a free mobile app from The North American Menopause Society (NAMS) to help clinicians and women work together to personalize treatment decisions based on a woman’s personal preferences (hormonal vs nonhormonal options), taking into account her medical history and risk factor status. The app has two modes, one for clinicians and one for women, to facilitate shared decision making. MenoPro is available for iOS (iPhone, iPad) and Android devices.
The MenoPro app has several unique features, including the ability to calculate a woman’s 10-year cardiovascular disease risk score, which can be incorporated into clinical decision making. It also has links to the Gail breast cancer assessment tool and to the FRAX® fracture risk assessment tool.
MenoPro was developed in collaboration with NAMS and includes links to NAMS education materials, including a downloadable MenoNote on behavior and lifestyle modifications to reduce hot flashes, and information pages on the pros and cons of hormonal versus nonhormonal therapy, including contraindications and cautions, a discussion of transdermal versus oral therapy, and information on treatment options for genitourinary symptoms. These pages can be printed out or directly emailed to women. There are also links to tables with information on the different formulations and doses of medications.
Clinicians may want to read the open-access Menopause editorial about the app, “Algorithm and Mobile App for Menopausal Symptom Management and Hormonal/Non-Hormonal Therapy Decision Making: A Clinical Decision-Support Tool From The North American Menopause Society.”
MenoPro contains no advertising and was developed without any industry or pharmaceutical company support.
We hope this mobile app will be helpful to clinicians in their clinical practices and to women in helping them make informed choices about the management of menopause symptoms.